Roche's Full-Year Earnings: Solid, No Alarms - Obesity Promise Makes The Buy Case [Seeking Alpha]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Seeking Alpha
RHHBY's pipeline, especially in obesity and cardiovascular, positions it as a potential third major player in the GLP-1 market. Management guides for mid-single-digit sales and high-single-digit core EPS growth in 2026, alongside a dividend increase. I maintain a Buy rating on RHHBY stock, citing a strong product portfolio, a rich pipeline, and no clear threats to growth through 2030. Looking for a portfolio of ideas like this one? Members of Haggerston BioHealth get exclusive access to our subscriber-only portfolios. Learn More » Sinenkiy/iStock via Getty Images Investment Overview The Swiss Pharma giant Hoffman-La Roche, aka Roche Holding AG ( RHHBY ), reported its full-year 2025 earnings this morning prior to market open. I gave Roche stock a Buy rating in More on my IG service If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations a
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging [Yahoo! Finance]Yahoo! Finance
- SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech [Yahoo! Finance]Yahoo! Finance
- Natera Submits Signatera™ CDx PMA to FDA [Yahoo! Finance]Yahoo! Finance
- Roche's CT-388 Obesity Data Tests New Growth Pillar Potential [Yahoo! Finance]Yahoo! Finance
- Diagnostic Enzymes Research Report 2026 - Global $8.72 Bn Market Trends, Opportunities, and Forecasts to 2031 [Yahoo! Finance]Yahoo! Finance